June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Level of Diabetic Retinopathy Severity Correlates to Degree of Quadrant Asymmetry in OCTA Metrics
Author Affiliations & Notes
  • Jesse J Jung
    East Bay Retina Consultants, Inc, California, United States
    Ophthalmology, University of California San Francisco, San Francisco, California, United States
  • Shen Yi Lim
    Singapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS Medical School, Singapore, Singapore
  • Xavier Chan
    Singapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS Medical School, Singapore, Singapore
  • Quan V Hoang
    Singapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS Medical School, Singapore, Singapore
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Footnotes
    Commercial Relationships   Jesse Jung Carl Zeiss Meditec, Inc., Code C (Consultant/Contractor); Shen Yi Lim None; Xavier Chan None; Quan Hoang None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2900 – F0053. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jesse J Jung, Shen Yi Lim, Xavier Chan, Quan V Hoang; Level of Diabetic Retinopathy Severity Correlates to Degree of Quadrant Asymmetry in OCTA Metrics. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2900 – F0053.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Asymmetry among the ETDRS quadrants on en-face OCTA metrics (superficial [SRL] and deep retinal layer [DRL] perfusion density [PD] and vessel density [VD]) allows for intra-eye comparisons and possibly mitigates inter-eye variabilities such as refractive error, age, axial length, and magnification. Herein, we assess the effect of the level of diabetic retinopathy (DR) on quadrant asymmetry (QA) with en-face OCTA

Methods : 90 eyes (60 patients) [27 non-diabetic (noDM); 12 diabetics without DR (noDR); 11 mild, 10 moderate (mod) and 7 severe (sev) non-proliferative DR (NPDR); and 23 proliferative DR (PDR)] underwent 3x3mm OCTA scans (signal >7, fovea-centered and auto-segmented for SRL/DRL). QA was defined as the max-min value among 4 ETDRS quadrants for a given eye in terms of OCTA metrics for the SRL and DRL and was compared to DR severity by linear regression including fixed effects for each individual eye

Results : Mean age was 55.5 years (range 24-88) with 60% male. QA for SRL VD was 1.87, 1.95, 1.69, 2.37, 2.38 and 3.13 for noDM, noDR, mild, mod, sev and PDR, respectively. QA for SRL PD was 0.028, 0.035, 0.028, 0.046, 0.045 and 0.061, for DRL VD was 2.17, 1.76, 1.78, 2.38, 2.90 and 3.25, and for DRL PD was 0.037, 0.036, 0.033, 0.056, 0.071 and 0.069 for noDM, noDR, mild, mod, sev and PDR, respectively. Linear regression demonstrated for every step increase in DR severity, there was a 0.34 increase in QA (p<0.001) for SRL VD, +0.008 SRL PD (p<0.001), +0.41 DRL VD (p<0.001), and +0.010 DRL PD (p<0.001). QA for both SRL VD and PD were significantly higher in eyes with sev or PDR when compared to noDM or noDR eyes (+0.23 and +0.004, p<0.001). QA for both DRL VD and PD were significantly higher in eyes with mild or mod when compared to noDM or noDR eyes (+0.15, p=0.04 and +0.003, p=0.02)

Conclusions : DR severity affects PD and VD more asymmetrically across the 4 ETDRS quadrants with a linear increase in QA for each worsening level of DR. Clinically significant increase in QA occurs when eyes are worse than mod NPDR in the SRL and > mild NPDR in the DRL. Individual intra-eye metrics such as QA can be utilized to quantify DR severity without concerns for inter-eye variabilities that could affect the reproducibility and reliability of OCTA quantification

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×